Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

To identify producers of specific APIs

— Market research, Germany

To know the expiration dates of several pharmaceuticals products

— Pharmaceutical company, Spain

To gain knowledge on formulations of different drugs

— Product development officer, Pharmaceutical company, Bangladesh

To analyze generic candidates using patent expiration data

— Portfolio management, Indonesia

To find expiring patents for generic product development

— Product manager, Saudi Arabia

Generated: May 27, 2017

DrugPatentWatch Database Preview

DEPO-SUBQ PROVERA 104 Drug Profile

« Back to Dashboard

What is the patent landscape for Depo-subq Provera 104, and what generic Depo-subq Provera 104 alternatives are available?

Depo-subq Provera 104 is a drug marketed by Pharmacia And Upjohn and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-eight patent family members in twenty-eight countries.

The generic ingredient in DEPO-SUBQ PROVERA 104 is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

Summary for Tradename: DEPO-SUBQ PROVERA 104

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list41
Clinical Trials: see list146
Patent Applications: see list8,403
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEPO-SUBQ PROVERA 104 at DailyMed

Pharmacology for Tradename: DEPO-SUBQ PROVERA 104

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
ADD ALERT
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
DEPO-SUBQ PROVERA 104
medroxyprogesterone acetate
INJECTABLE;SUBCUTANEOUS021583-001Dec 17, 2004RXYesYes6,495,534► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To get patent/product expiration details and freedom-to-operate opportunities

— API development, India

To get patent expiration dates and find out when generics plan to advertise and enter the market

— Pharmacist, USA

To research drug patent expirations and NCE dates

— Patent attorney, USA

To know which brands are on and off patent

— Advertising sales pharma companies, USA

For information on medications and their innovator companies, as well as their patency profiles

— Pharmacist, Nigeria

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot